Mayadevi Polycot Limited Discloses Acquisition of IOL Chemicals & Pharmaceuticals Shares

1773914797280.webp

Mayadevi Polycot Limited Discloses Acquisition of IOL Chemicals & Pharmaceuticals Shares​

Mayadevi Polycot Limited has acquired 54,197 equity shares of IOL Chemicals and Pharmaceuticals Limited through open market transactions on March 19, 2026. The disclosure was made under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

According to the filing, Varinder Gupta, Varinder Gupta (HUF), NCVI Enterprises Limited, and Mayadevi Polycot Limited collectively held 16,75,58,303 shares, representing 57.08% of the total share/voting capital and 57.08% of the total diluted share/voting capital of IOL Chemicals and Pharmaceuticals Limited prior to the acquisition.

The acquisition of the 54,197 shares increased the collective holding to 16,76,12,500 shares, representing 57.10% of the total share/voting capital and 57.10% of the total diluted share/voting capital of IOL Chemicals and Pharmaceuticals Limited. The total equity share capital of IOL Chemicals and Pharmaceuticals Limited is Rs. 58,70,55,020, equivalent to 29,35,27,510 equity shares of Rs. 2 each.

Shareholding Details

The following table summarizes the shareholding details:

DetailVarinder GuptaVarinder Gupta (HUF)Mayadevi Polycot LimitedNM Merchantiles LimitedNCVI Enterprises Limited
Shares carrying voting rights before acquisition59,79,3255,5006,38,91,1335,01,31,6504,75,50,695
Total Shares carrying voting rights before acquisition16,75,58,303
Shares acquired54,197
Total Shares carrying voting rights after acquisition
% w.r.t. total share/voting capital
% w.r.t. total diluted share/voting capital

Varinder Gupta serves as Director of Mayadevi Polycot Limited (DIN: 00044068).

Source:​

 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Last edited by a moderator:

Editorial Note

This news article was written and created by Karthik, and published on IST.
Back
Top